Rhenman & Partners Asset Management AB / ABMDEUR
Rhenman & Partners Asset Management AB’s Abiomed Inc Position
Does Rhenman & Partners Asset Management AB own Abiomed Inc (ABMDEUR)? Not currently — the last reported position was 85.9K shares worth $22M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$22M
Q3 2022
Shares
85.9K
% of Portfolio
+2.27%
Quarters Held
16
position exited
Position History ABMDEUR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 85.9K | $22M | +2.27% |
| Q2 2022 | 73.0K | $18M | +2.05% |
| Q1 2022 | 68.0K | $23M | +2.22% |
| Q4 2021 | 52.0K | $19M | +1.25% |
| Q3 2021 | 70.0K | $23M | +1.60% |
| Q2 2021 | 65.0K | $20M | +1.38% |
| Q1 2021 | 78.0K | $25M | +1.73% |
| Q4 2020 | 63.0K | $20M | +1.67% |
| Q3 2020 | 70.0K | $19M | +1.72% |
| Q2 2020 | 68.0K | $16M | +1.77% |
| Q1 2020 | 88.0K | $13M | +1.79% |
| Q4 2019 | 87.0K | $15M | +1.63% |
| Q3 2019 | 120.0K | $21M | +2.68% |
| Q2 2019 | 92.9K | $24M | +2.67% |
| Q1 2019 | 92.5K | $26M | +3.09% |
| Q4 2018 | 65.3K | $21M | +2.43% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rhenman & Partners Asset Management AB’s full portfolio or all institutional holders of ABMDEUR.